Literature DB >> 19129446

Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.

Hiroaki Uchida1, Waris A Shah, Ali Ozuer, Arthur R Frampton, William F Goins, Paola Grandi, Justus B Cohen, Joseph C Glorioso.   

Abstract

Both initial infection and cell-to-cell spread by herpes simplex virus type 1 (HSV-1) require the interaction of the viral glycoprotein D (gD) with an entry receptor on the cell surface. The two major HSV entry receptors, herpesvirus entry mediator (HVEM) and nectin-1, mediate infection independently but are coexpressed on a variety of cells. To determine if both receptors are active in these instances, we have established mutant viruses that are selectively impaired for recognition of one or the other receptor. In plaque assays, these viruses showed approximately 1,000-fold selectivity for the matched receptor over the mismatched receptor. Separate assays showed that each virus is impaired for both infection and spread through the mismatched receptor. We tested several human tumor cell lines for susceptibility to these viruses and observed that HT29 colon carcinoma cells are susceptible to infection by nectin-1-restricted virus but are highly resistant to HVEM-restricted virus infection, despite readily detectable HVEM expression on the cell surface. HVEM cDNA isolated from HT29 cells rendered HSV-resistant cells permissive for infection by the HVEM-restricted virus, suggesting that HT29 cells lack a cofactor for HVEM-mediated infection or express an HVEM-specific inhibitory factor. Passaging of HVEM-restricted virus on nectin-1-expressing cells yielded a set of gD missense mutations that each restored functional recognition of nectin-1. These mutations identify residues that likely play a role in shaping the nectin-1 binding site of gD. Our findings illustrate the utility of these receptor-restricted viruses in studying the early events in HSV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129446      PMCID: PMC2655597          DOI: 10.1128/JVI.01449-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread.

Authors:  D A Rauch; N Rodriguez; R J Roller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.

Authors:  N Fournier; L Chalus; I Durand; E Garcia; J J Pin; T Churakova; S Patel; C Zlot; D Gorman; S Zurawski; J Abrams; E E Bates; P Garrone
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

Review 3.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals.

Authors:  Frank Struyf; Christine M Posavad; Els Keyaerts; Marc Van Ranst; Lawrence Corey; Patricia G Spear
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

5.  Herpes simplex virus glycoprotein D bound to the human receptor HveA.

Authors:  A Carfí; S H Willis; J C Whitbeck; C Krummenacher; G H Cohen; R J Eisenberg; D C Wiley
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

6.  Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1.

Authors:  C G Miller; C Krummenacher; R J Eisenberg; G H Cohen; N W Fraser
Journal:  Mol Ther       Date:  2001-02       Impact factor: 11.454

7.  Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D.

Authors:  M Lopez; F Cocchi; L Menotti; E Avitabile; P Dubreuil; G Campadelli-Fiume
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A.

Authors:  D J Eling; P A Johnson; S Sharma; F Tufaro; T J Kipps
Journal:  Gene Ther       Date:  2000-07       Impact factor: 5.250

9.  Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1/HveC/HIgR) and nectin2 (PRR2/HveB).

Authors:  F Cocchi; L Menotti; P Dubreuil; M Lopez; G Campadelli-Fiume
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  Crystal structure of glycoprotein B from herpes simplex virus 1.

Authors:  Ekaterina E Heldwein; Huan Lou; Florent C Bender; Gary H Cohen; Roselyn J Eisenberg; Stephen C Harrison
Journal:  Science       Date:  2006-07-14       Impact factor: 47.728

View more
  24 in total

1.  Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Authors:  Hyunjung Baek; Hiroaki Uchida; Kyungok Jun; Jae-Hong Kim; Masahide Kuroki; Justus B Cohen; Joseph C Glorioso; Heechung Kwon
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

3.  Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.

Authors:  Doina Atanasiu; Wan Ting Saw; John R Gallagher; Brian P Hannah; Zene Matsuda; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

4.  Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Authors:  T Shibata; H Uchida; T Shiroyama; Y Okubo; T Suzuki; H Ikeda; M Yamaguchi; Y Miyagawa; T Fukuhara; J B Cohen; J C Glorioso; T Watabe; H Hamada; H Tahara
Journal:  Gene Ther       Date:  2016-02-23       Impact factor: 5.250

5.  Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.

Authors:  Yu Okubo; Hiroaki Uchida; Aika Wakata; Takuma Suzuki; Tomoko Shibata; Hitomi Ikeda; Miki Yamaguchi; Justus B Cohen; Joseph C Glorioso; Mitsuo Tagaya; Hirofumi Hamada; Hideaki Tahara
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

6.  A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.

Authors:  Hiroaki Uchida; Janet Chan; William F Goins; Paola Grandi; Izumi Kumagai; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

7.  A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM.

Authors:  Kening Wang; Justin D Kappel; Caleb Canders; Wilmer F Davila; Dean Sayre; Mayra Chavez; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

8.  Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

Authors:  Hiroaki Uchida; Marco Marzulli; Kenji Nakano; William F Goins; Janet Chan; Chang-Sook Hong; Lucia Mazzacurati; Ji Young Yoo; Amy Haseley; Hiroshi Nakashima; Hyunjung Baek; Heechung Kwon; Izumi Kumagai; Masahide Kuroki; Balveen Kaur; E Antonio Chiocca; Paola Grandi; Justus B Cohen; Joseph C Glorioso
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

9.  Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread.

Authors:  Hiroaki Uchida; Janet Chan; Indira Shrivastava; Bonnie Reinhart; Paola Grandi; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 10.  Retargeting of herpes simplex virus (HSV) vectors.

Authors:  William F Goins; Bonnie Hall; Justus B Cohen; Joseph C Glorioso
Journal:  Curr Opin Virol       Date:  2016-09-08       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.